OrthoPediatrics Corp.
OrthoPediatrics Corp.
Your view on KIDS
Overview
What the company does, where it operates, and who runs it.
About OrthoPediatrics Corp.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- David R. Bailey
- Headquarters
- 2850 Frontier Drive, Warsaw, IN, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- David R. Bailey
- Headquarters
- 2850 Frontier Drive, Warsaw, IN, US
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally.
The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system.
The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for OrthoPediatrics Corp., and the rating behind it. KIDS last traded at $22.06; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for OrthoPediatrics Corp.. Starting points for OrthoPediatrics Corp.: EPS -$1.66, beta 0.98 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for OrthoPediatrics Corp.. OrthoPediatrics Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for OrthoPediatrics Corp.. Trailing twelve-month EPS for OrthoPediatrics Corp. stands at -$1.66. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for OrthoPediatrics Corp.. OrthoPediatrics Corp. has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
OrthoPediatrics Corp. valued side by side against its closest peers. OrthoPediatrics Corp. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold OrthoPediatrics Corp., and how their positions are changing. At a $566.6M market value, institutional positions materially move OrthoPediatrics Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by OrthoPediatrics Corp. executives and directors. Shares of OrthoPediatrics Corp. have traded between $15.28 and $27.60 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming OrthoPediatrics Corp.. OrthoPediatrics Corp. is a $566.6M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming OrthoPediatrics Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for OrthoPediatrics Corp.. Coverage tracks OrthoPediatrics Corp. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.